Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers.
Accurate prediction of clinical changes of mild cognitive impairment (MCI) patients, including both qualitative change (i.e., conversion to Alzheimer's disease (AD)) and quantitative change (i.e., cognitive scores) at future time points, is important for early diagnosis of AD and for monitoring...
| Published in: | PLoS ONE |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22457741/?tool=EBI |